Other technical consultancy
NORSE BIOTECH AS
Revenue 2024
NOK 351,000
Operating profit
NOK −434,000
Equity
NOK 2.1m
Incorporated
2015
Share capital
NOK 588,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 351k | |
| Total operating costs | 785k | |
| Operating profit (EBIT) | −434k | |
| Net financial items | −4k | |
| Profit for the year | −438k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 4.0m | |
| of which current assets | 575k | |
| Equity | 2.1m | |
| Total liabilities | 1.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.